Therapy Areas: Diabetes
Unmanaged Diabetes Associated with Greater COVID-19 Severity, Study Indicates
28 June 2021 - - A new study reveals unmanaged diabetes is a key factor in COVID-19 severity and complications, particularly among Hispanic and Latinx populations. Findings of the retrospective study were presented at the virtual 81st Scientific Sessions of the American Diabetes Association (ADA).

Forty percent of Americans who have died of COVID-19 have had diabetes, and 1 in 10 people with diabetes hospitalized for COVID-19 die within one week making diabetes a high-risk comorbidity.

When left untreated, diabetes can lead to increased overall health complication.

Yet, nearly 1 in 5 Americans with diabetes report that due to the increased financial constraints of the pandemic they had to choose between buying food or buying medications and medical supplies required to manage their diabetes.

The study sought to determine the impact of unmanaged diabetes, or a lack of medication use, on COVID-19 severity and recovery within in a predominately Hispanic population -- a population 2.4 times more likely to die of COVID-19 and 50% more likely to have diabetes than white Americans.

The retrospective study was conducted by a multidisciplinary team lead by Dr. Sudip Bajpeyi, director of the MiNER laboratory, at the University of the Texas at El Paso and was presented by his master's student Ali Mossayebi.

This study used medical records from 369 patients admitted to the University Medical Center, El Paso, TX with COVID-19. Patients were categorized based on A1C levels into normoglycemic (N: A1C